SHENZHEN, China, Aug. 18, 2025 /PRNewswire/ — Jarnistech, a PCB manufacturer specializing in high-end multilayer and specialty material boards, has recently launched its glass-based PCB solution. The solution has already been adopted in customer prototype validation projects, targeting applications that demand tight control over signal loss, thermal stability, and optical transparency. Continue Reading Jarnistech’s PCB Factory… Continue reading Jarnistech Launches Glass Substrate Solutions, Breaking Through the Boundaries of Next-Generation PCB Materials
Tag: Financial Results
Investor Alert: Robbins LLP Informs Investors of the Charter Communications, Inc. Class Action
SAN DIEGO, Aug. 18, 2025 /PRNewswire/ — Robbins LLP informs stockholders that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Charter Communications, Inc. (NASDAQ: CHTR) securities, purchased call options on Charter common stock, or sold put options on Charter common stock, between July 26, 2024 and July 24,… Continue reading Investor Alert: Robbins LLP Informs Investors of the Charter Communications, Inc. Class Action
Investor Alert: Robbins LLP Informs Investors of the Unicycive Therapeutics, Inc. Class Action
SAN DIEGO, Aug. 18, 2025 /PRNewswire/ — Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Unicycive Therapeutics, Inc. (NASDAQ: UNCY) securities between March 29, 2024 and June 27, 2025. Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies to address unmet medical… Continue reading Investor Alert: Robbins LLP Informs Investors of the Unicycive Therapeutics, Inc. Class Action
TCL appoints Olympic ski champion Eileen Gu as Global Brand Ambassador
SHENZHEN, China, Aug. 18, 2025 /PRNewswire/ — TCL, a global technology company, has appointed freestyle skier Eileen Gu as their Global Brand Ambassador. Her appointment is part of TCL’s commitment to advancing the Olympic Movement as a Worldwide Olympic Partner. Having become the youngest Olympic champion in freestyle skiing at the age of 18, and the… Continue reading TCL appoints Olympic ski champion Eileen Gu as Global Brand Ambassador
TCL appoints Olympic ski champion Eileen Gu as Global Brand Ambassador
SHENZHEN, China, Aug. 17, 2025 /PRNewswire/ — TCL, a global technology company, has appointed freestyle skier Eileen Gu as their Global Brand Ambassador. Her appointment is part of TCL’s commitment to advancing the Olympic Movement as a Worldwide Olympic Partner. Having become the youngest Olympic champion in freestyle skiing at the age of 18, and the… Continue reading TCL appoints Olympic ski champion Eileen Gu as Global Brand Ambassador
Houston Boston Partners Expands AutoShop Answers Leadership, Appoints Award Winning Cinematographer Joshua Spires as Creative Director & General Managing Partner of AutoShop Media
Fortune 500 Level Infrastructure Driving Innovation, Storytelling, AI Integration, and Growth Across the Nation’s Largest and Most Advanced Independent Automotive Service Platform HOUSTON, Aug. 17, 2025 /PRNewswire/ — Houston Boston Partners (HBP), the nation’s largest platform of world class, independently owned automotive service centers, today announced the appointment of award winning cinematographer Joshua Spires as… Continue reading Houston Boston Partners Expands AutoShop Answers Leadership, Appoints Award Winning Cinematographer Joshua Spires as Creative Director & General Managing Partner of AutoShop Media
Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal Model of Obesity
– Combination of a low dose of ASC47 with ASC31, a novel peptide agonist targeting both GLP-1 receptor (GLP-1R) and GIP receptor (GIPR), resulted in a 44.8% reduction in body weight after 14 days of treatment in a diet-induced obese (DIO) mouse model. – Combination of a low dose of ASC47 with ASC31 demonstrated statistically… Continue reading Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal Model of Obesity
KLC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that KinderCare Learning Companies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Aug. 17, 2025 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against KinderCare Learning Companies, Inc. (“KinderCare” or “the Company”) (NYSE: KLC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for… Continue reading KLC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that KinderCare Learning Companies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
LINE Investors Have Opportunity to Lead Lineage, Inc. Securities Lawsuit
NEW YORK, Aug. 17, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Lineage, Inc. (NASDAQ: LINE) pursuant and/or traceable to the registration statement issued in connection with Lineage’s July 2024 initial public offering (the… Continue reading LINE Investors Have Opportunity to Lead Lineage, Inc. Securities Lawsuit
GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation
Rising Global Footprint, Best-in-Class Innovation, and ESG Excellence Set Stage for Sustained Value Creation PISCATAWAY, N.J., Aug. 17, 2025 /PRNewswire/ — GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the first half of 2025, underscoring its ability to deliver profitable growth at scale through strategic globalization,… Continue reading GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation